Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease

Not Applicable

Completed

• Conditions: Patients With Gaucher's Disease

• Registration Number: NCT01206673
• Lead Sponsor: Nantes University Hospital

Brief Summary

The aim of this study is to evaluate macrophaging activity and immunologic profile of patients with Gaucher 's disease. For this, one blood sampling will be performed.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-12
• Study First Submitted: 2010-09-21
• Study First Submitted QC: 2010-09-21
• Study First Posted: 2010-09-22
• Primary Completion: 2011-07
• Study Completion: 2011-07
• Status Verified: 2011-12
• Last Update Submitted: 2011-12-01
• Last Update Posted: 2011-12-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Adults (age equal or above 18.
• Patients with Gaucher 's disease treated in the "Grand Ouest" competence center
• patients affiliated to social security
• Informed consent signed

Exclusion Criteria

• Children (age<18)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
To determine the implication of acquired and inherent immunity in the Gaucher's clinical phenotype at moment of blood sampling

Secondary Outcome Measures

Name	Time	Method
to find new activity mark for Gaucher's disease by studying macrophagic activation's markers.

Trial Locations

Locations (2)

CHU of Rennes; 🇫🇷 Rennes, France

Nantes Hospital; 🇫🇷 Nantes, France